Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 4
2015 1
2016 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Signaling pathways involved in MDSC regulation.
Trikha P, Carson WE 3rd. Trikha P, et al. Biochim Biophys Acta. 2014 Aug;1846(1):55-65. doi: 10.1016/j.bbcan.2014.04.003. Epub 2014 Apr 13. Biochim Biophys Acta. 2014. PMID: 24727385 Free PMC article. Review.
Myeloid-derived suppressor cells in breast cancer.
Markowitz J, Wesolowski R, Papenfuss T, Brooks TR, Carson WE 3rd. Markowitz J, et al. Breast Cancer Res Treat. 2013 Jul;140(1):13-21. doi: 10.1007/s10549-013-2618-7. Epub 2013 Jul 5. Breast Cancer Res Treat. 2013. PMID: 23828498 Free PMC article. Review.
Structural characterization of NRAS isoform 5.
Markowitz J, Mal TK, Yuan C, Courtney NB, Patel M, Stiff AR, Blachly J, Walker C, Eisfeld AK, de la Chapelle A, Carson WE 3rd. Markowitz J, et al. Protein Sci. 2016 May;25(5):1069-74. doi: 10.1002/pro.2916. Epub 2016 Mar 24. Protein Sci. 2016. PMID: 26947772 Free PMC article.
A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia.
Byrd JC, Pagel JM, Awan FT, Forero A, Flinn IW, Deauna-Limayo DP, Spurgeon SE, Andritsos LA, Gopal AK, Leonard JP, Eisenfeld AJ, Bannink JE, Stromatt SC, Furman RR. Byrd JC, et al. Blood. 2014 Feb 27;123(9):1302-8. doi: 10.1182/blood-2013-07-512137. Epub 2013 Dec 31. Blood. 2014. PMID: 24381226 Free PMC article. Clinical Trial.
A phase I trial of bortezomib and interferon-α-2b in metastatic melanoma.
Markowitz J, Luedke EA, Grignol VP, Hade EM, Paul BK, Mundy-Bosse BL, Brooks TR, Dao TV, Kondalasula SV, Lesinski GB, Olencki T, Kendra KL, Carson WE 3rd. Markowitz J, et al. J Immunother. 2014 Jan;37(1):55-62. doi: 10.1097/CJI.0000000000000009. J Immunother. 2014. PMID: 24316557 Free PMC article. Clinical Trial.